Skip to main content

Animations

MJFF Publications

5351 - 5360 of 6420 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2025
  • 2017
  • 2016
  • 2016
  • 2021
  • 2021
  • 2022
  • 2015
  • Summary Details
    OPEN
    Title: Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00460-w
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Tau protein aggregation associated with SARS-CoV-2 main protease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0288138
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrils
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.106820
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.447
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2
    Journal Name: Frontiers in Molecular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnmol.2015.00089
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Synthesis of a Bis-thio-acetone (BTA) Analogue of the Lysine Isopeptide Bond and its Application to Investigate the Effects of Ubiquitination and SUMOylation on α-Synuclein Aggregation and Toxicity
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschembio.5b01042
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Gait Parameters Measured from Wearable Sensors Reliably Detect Freezing of Gait in a Stepping in Place Task
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s21082661
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2021.102569
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The Interaction between HLA‐DRB1 and Smoking in Parkinson's Disease Revisited
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.29133
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032
    Citation Count: 41
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.